The latest product launches, like CellFE’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New product launches, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Launch Trends
See who's moving and how much in your market
No credit card required Weekly product launch digest
CellFE Launches T-Rest ('Resting T Cell Kit') to Enhance CAR-T Cell Therapy Manufacturing
CellFE has introduced T-Rest, a novel transfection media product specifically designed for resting T cell workflows in CAR-T cell therapy. This product aims to optimize gene editing workflows, promoting safer and more effective therapies by utilizing resting T cells.
Company Information
Company
CellFE
Location
Alameda, California, United States
About
CellFE is an innovative microfluidics company, whose mission is to transform the development and manufacturing of lifesaving cell therapies to make them more accessible to patients. The company uses a microfluidic-based cell engineering platform with highest cell health and payload delivery, streamlined scalability and automated workflows. Platform benefits include increased cell yield and reduced expansion times that translate to drastically reduced vein-to-vein times and manufacturing costs currently associated with advanced cell therapies. CellFE is committed to enabling their partners' success through close collaborations that aim to solve the challenges associated with the development and manufacturing of next generation cell therapies. https://www.cellfebiotech.com/
AlamedaManufacturingBiotechnologyHealth CareTherapeutics